Alvaro Gallo-Cordova
Overview
Explore the profile of Alvaro Gallo-Cordova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DeDiego M, Portilla Y, Daviu N, Lopez-Garcia D, Villamayor L, Vazquez-Utrilla P, et al.
Int J Nanomedicine
. 2024 Dec;
19:13763-13788.
PMID: 39723174
Background: Severe Acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) and Influenza A viruses (IAVs) are among the most important causes of viral respiratory tract infections, causing similar symptoms. IAV and SARS-CoV-2...
2.
Egea-Benavente D, Diaz-Ufano C, Gallo-Cordova A, Palomares F, Cuya Huaman J, Barber D, et al.
ACS Appl Mater Interfaces
. 2023 Jun;
15(27):32162-32176.
PMID: 37390112
Magnetic iron oxide mesocrystals have been reported to exhibit collective magnetic properties and consequently enhanced heating capabilities under alternating magnetic fields. However, there is no universal mechanism to fully explain...
3.
Porru M, Morales M, Gallo-Cordova A, Espinosa A, Moros M, Brero F, et al.
Nanomaterials (Basel)
. 2022 Oct;
12(19).
PMID: 36234433
Tuning the fundamental properties of iron oxide magnetic nanoparticles (MNPs) according to the required biomedical application is an unsolved challenge, as the MNPs' properties are affected by their composition, their...
4.
DeDiego M, Portilla Y, Daviu N, Lopez-Garcia D, Villamayor L, Mulens-Arias V, et al.
J Nanobiotechnology
. 2022 Jul;
20(1):352.
PMID: 35907835
Background: Coronaviruses usually cause mild respiratory disease in humans but as seen recently, some human coronaviruses can cause more severe diseases, such as the Severe Acute Respiratory Syndrome Coronavirus 2...
5.
Alvarez E, Estevez M, Gallo-Cordova A, Gonzalez B, Castillo R, Morales M, et al.
Pharmaceutics
. 2022 Jan;
14(1).
PMID: 35057058
A crucial challenge to face in the treatment of biofilm-associated infection is the ability of bacteria to develop resistance to traditional antimicrobial therapies based on the administration of antibiotics alone....
6.
Estevez M, Montalbano G, Gallo-Cordova A, Ovejero J, Izquierdo-Barba I, Gonzalez B, et al.
Nanomaterials (Basel)
. 2022 Jan;
12(2).
PMID: 35055200
Nowadays, there is an ever-increasing interest in the development of systems able to guide and influence cell activities for bone regeneration. In this context, we have explored for the first...
7.
Gallo-Cordova A, Ovejero J, Pablo-Sainz-Ezquerra A, Cuya J, Jeyadevan B, Veintemillas-Verdaguer S, et al.
J Colloid Interface Sci
. 2021 Nov;
608(Pt 2):1585-1597.
PMID: 34742075
Elucidation of reaction mechanisms in forming nanostructures is relevant to obtain robust and affordable protocols that can lead to materials with enhanced properties and good reproducibility. Here, the formation of...
8.
Ovejero J, Gallo-Cordova A, Roca A, Morales M, Veintemillas-Verdaguer S
Nanomaterials (Basel)
. 2021 Aug;
11(8).
PMID: 34443890
The application of magnetic nanoparticles requires large amounts of materials of reproducible quality. This work explores the scaled-up synthesis of multi-core iron oxide nanoparticles through the use of thermal decomposition...
9.
Gallo-Cordova A, Veintemillas-Verdaguer S, Tartaj P, Mazario E, Morales M, Ovejero J
Nanomaterials (Basel)
. 2021 Apr;
11(4).
PMID: 33924017
Advanced oxidation processes constitute a promising alternative for the treatment of wastewater containing organic pollutants. Still, the lack of cost-effective processes has hampered the widespread use of these methodologies. Iron...
10.
Salvador M, Gallo-Cordova A, Moyano A, Martinez-Garcia J, Blanco-Lopez M, Morales M, et al.
Analyst
. 2020 Aug;
145(17):5905-5914.
PMID: 32830828
Lateral flow assays may be used by minimally trained personnel for fast and inexpensive bioanalyses in decentralized non-exigent environments. Their extension to a broader catalog of applications depends on improvements...